The critical role of the MyD88-dependent pathway in non-CNS MPTP-mediated toxicity

Brain, Behavior, and Immunity

Volumn 25, Issue 6, 2011, Pages 1143-1152

  Cote M ^a   Drouin Ouellet, J ^a   Cicchetti, F ^a,b   Soulet, D ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

1 Methyl 4 phenyl 1,2,3,6 tetrahydropyridine; Ileum; Inflammation; Macrophage; MyD88; Myenteric plexus; Tyrosine hydroxylase

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; MYELOID DIFFERENTIATION FACTOR 88; TOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; CELL DENSITY; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; IMMUNE RESPONSE; IMMUNOREACTIVITY; INFLAMMATION; INNATE IMMUNITY; KNOCKOUT MOUSE; MACROPHAGE; MOUSE; MYENTERIC PLEXUS; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; WILD TYPE;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; DOPAMINE; ILEITIS; ILEUM; IMMUNITY, INNATE; IMMUNITY, MUCOSAL; INTESTINAL MUCOSA; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MPTP POISONING; MYELOID DIFFERENTIATION FACTOR 88; MYENTERIC PLEXUS; NERVE DEGENERATION; NEUROIMMUNOMODULATION; NEURONS; NEUROTOXINS; NEUTROPHILS; TYROSINE 3-MONOOXYGENASE;

EID: 79960282591     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2011.02.017     Document Type: Article

References (37)

1. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
2. Anderson G., Noorian A.R., Taylor G., Anitha M., Bernhard D., Srinivasan S., Greene J.G. Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease. Exp. Neurol. 2007, 207:4-12.
3. Anitha M., Gondha C., Sutliff R., Parsadanian A., Mwangi S., Sitaraman S.V., Srinivasan S. GDNF rescues hyperglycemia-induced diabetic enteric neuropathy through activation of the PI3K/Akt pathway. J. Clin. Invest. 2006, 116:344-356.
4. Anlauf M., Schafer M.K., Eiden L., Weihe E. Chemical coding of the human gastrointestinal nervous system: cholinergic, VIPergic, and catecholaminergic phenotypes. J. Comp. Neurol. 2003, 459:90-111.
5. Apetoh L., Ghiringhelli F., Tesniere A., Obeid M., Ortiz C., Criollo A., Mignot G., Maiuri M.C., Ullrich E., Saulnier P., Yang H., Amigorena S., Ryffel B., Barrat F.J., Saftig P., Levi F., Lidereau R., Nogues C., Mira J.P., Chompret A., Joulin V., Clavel-Chapelon F., Bourhis J., Andre F., Delaloge S., Tursz T., Kroemer G., Zitvogel L. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat. Med. 2007, 13:1050-1059.
6. Chaumette T., Lebouvier T., Aubert P., Lardeux B., Qin C., Li Q., Accary D., Bezard E., Bruley des Varannes S., Derkinderen P., Neunlist M. Neurochemical plasticity in the enteric nervous system of a primate animal model of experimental Parkinsonism. Neurogastroenterol. Motil. 2009, 21:215-222.
7. Eaker E.Y., Bixler G.B., Dunn A.J., Moreshead W.V., Mathias J.R. Chronic alterations in jejunal myoelectric activity in rats due to MPTP. Am. J. Physiol. 1987, 253:G809-G815.
8. Gibrat C., Saint-Pierre M., Bousquet M., Levesque D., Rouillard C., Cicchetti F. Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and alpha-synuclein inclusions. J. Neurochem. 2009, 109:1469-1482.
9. Hirsch E.C., Hunot S. Neuroinflammation in Parkinson's disease: a target for neuroprotection?. Lancet Neurol. 2009, 8:382-397.
10. Hoffmann O., Braun J.S., Becker D., Halle A., Freyer D., Dagand E., Lehnardt S., Weber J.R. TLR2 mediates neuroinflammation and neuronal damage. J. Immunol. 2007, 178:6476-6481.
11. Holst M.C., Powley T.L. Cuprolinic blue (quinolinic phthalocyanine) counterstaining of enteric neurons for peroxidase immunocytochemistry. J. Neurosci. Methods 1995, 62:121-127.
12. Huang L.K., Wang M.J. Image thresholding by minimizing the measure of fuzziness. Pattern Recognit. 1995, 28:41-51.
13. Janssens S., Beyaert R. A universal role for MyD88 in TLR/IL-1R-mediated signaling. Trends Biochem. Sci. 2002, 27:474-482.
14. Kawai T., Akira S. Toll-like receptor and RIG-I-like receptor signaling. Ann. NY Acad. Sci. 2008, 1143:1-20.
15. Khallou-Laschet J., Varthaman A., Fornasa G., Compain C., Gaston A.T., Clement M., Dussiot M., Levillain O., Graff-Dubois S., Nicoletti A., Caligiuri G. Macrophage plasticity in experimental atherosclerosis. PLoS One 2010, 5:e8852.
16. Kohler C. Allograft inflammatory factor-1/Ionized calcium-binding adapter molecule 1 is specifically expressed by most subpopulations of macrophages and spermatids in testis. Cell Tissue Res. 2007, 330:291-302.
17. Lakhan S.E., Kirchgessner A. Neuroinflammation in inflammatory bowel disease. J. Neuroinflamm. 2010, 7:37.
18. Langston J.W., Forno L.S., Tetrud J., Reeves A.G., Kaplan J.A., Karluk D. Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann. Neurol. 1999, 46:598-605.
19. Li Z.S., Pham T.D., Tamir H., Chen J.J., Gershon M.D. Enteric dopaminergic neurons: definition, developmental lineage, and effects of extrinsic denervation. J. Neurosci. 2004, 24:1330-1339.
20. Liberatore G.T., Jackson-Lewis V., Vukosavic S., Mandir A.S., Vila M., McAuliffe W.G., Dawson V.L., Dawson T.M., Przedborski S. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat. Med. 1999, 5:1403-1409.
21. Mangla J.C., Pihan G., Brown H.A., Rattan S., Szabo S. Effect of duodenal ulcerogens cysteamine, mepirizole, and MPTP on duodenal myoelectric activity in rats. Dig. Dis. Sci. 1989, 34:537-542.
22. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004, 25:677-686.
23. Morris S.M. Arginine: master and commander in innate immune responses. Sci. Signal. 2010, 3:pe27.
24. Natale G., Kastsiushenka O., Fulceri F., Ruggieri S., Paparelli A., Fornai F. MPTP-induced parkinsonism extends to a subclass of TH-positive neurons in the gut. Brain Res. 2010, 1355:195-206.
25. Ortega-Cava C.F., Ishihara S., Rumi M.A., Kawashima K., Ishimura N., Kazumori H., Udagawa J., Kadowaki Y., Kinoshita Y. Strategic compartmentalization of Toll-like receptor 4 in the mouse gut. J. Immunol. 2003, 170:3977-3985.
26. Pineau I., Sun L., Bastien D., Lacroix S. Astrocytes initiate inflammation in the injured mouse spinal cord by promoting the entry of neutrophils and inflammatory monocytes in an IL-1 receptor/MyD88-dependent fashion. Brain Behav. Immun. 2010, 24:540-553.
27. Sharkey K.A., Kroese A.B. Consequences of intestinal inflammation on the enteric nervous system: neuronal activation induced by inflammatory mediators. Anat. Rec. 2001, 262:79-90.
28. Sharkey K.A., Mawe G.M. Neuroimmune and epithelial interactions in intestinal inflammation. Curr. Opin. Pharmacol. 2002, 2:669-677.
29. Singaram C., Ashraf W., Gaumnitz E.A., Torbey C., Sengupta A., Pfeiffer R., Quigley E.M. Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation. Lancet 1995, 346:861-864.
30. Smith P.F. Inflammation in Parkinson's disease: an update. Curr. Opin. Investig. Drugs 2008, 9:478-484.
31. Soulet D., Rivest S. Bone-marrow-derived microglia: myth or reality?. Curr. Opin. Pharmacol. 2008, 8:508-518.
32. Sriram K., Matheson J.M., Benkovic S.A., Miller D.B., Luster M.I., O'Callaghan J.P. Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease. FASEB J. 2002, 16:1474-1476.
33. Sugama S., Yang L., Cho B.P., DeGiorgio L.A., Lorenzl S., Albers D.S., Beal M.F., Volpe B.T., Joh T.H. Age-related microglial activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration in C57BL/6 mice. Brain Res. 2003, 964:288-294.
34. Szabo S. MPTP, gastroduodenal motility, duodenal ulceration, and Parkinson's disease. Dig. Dis. Sci. 1990, 35:666-667.
35. Vogl T., Tenbrock K., Ludwig S., Leukert N., Ehrhardt C., van Zoelen M.A., Nacken W., Foell D., van der Poll T., Sorg C., Roth J. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat. Med. 2007, 13:1042-1049.
36. Wakabayashi K., Takahashi H., Ohama E., Ikuta F. Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system. Acta Neuropathol. 1990, 79:581-583.
37. Wu D.C., Teismann P., Tieu K., Vila M., Jackson-Lewis V., Ischiropoulos H., Przedborski S. NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Proc. Natl. Acad. Sci. USA 2003, 100:6145-6150.